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This nationwide study found evidence of space-time clustering of childhood leukaemia 
around the time of birth but not at diagnosis nor for other diagnostic groups. The study is 
unique in that it corrects for uneven regional population shifts, a potential source of bias in 
earlier studies, at high geographic resolution. The small spatial (<1 km) and temporal (<2 
years) scale of the clustering could indicate a leukaemogenic infection occurring around birth 
or in utero. 
- 3 - 
Abstract 
The aetiology of childhood cancers remains largely unknown. It has been hypothesized that 
infections may be involved and that mini-epidemics thereof could result in space-time 
clustering of incident cases. Most previous studies support spatio-temporal clustering for 
leukaemia, while results for other diagnostic groups remain mixed. Few studies have 
corrected for uneven regional population shifts which can lead to spurious detection of 
clustering. We examined whether there is space-time clustering of childhood cancers in 
Switzerland identifying cases diagnosed in children aged <16 years between 1985 and 2010 
from the Swiss Childhood Cancer Registry. Knox tests were performed on geocoded 
residence at birth and diagnosis separately for leukaemia, acute lymphoid leukaemia (ALL), 
lymphomas, tumours of the central nervous system, neuroblastomas and soft tissue sarcomas. 
We used Baker’s Max statistic to correct for multiple testing and randomly sampled time-, 
sex- and age-matched controls from the resident population to correct for uneven regional 
population shifts. We observed space-time clustering of childhood leukaemia at birth (Baker’s 
max P = 0.045) but not at diagnosis (P = 0.98). Clustering was strongest for a spatial lag of <1 
km and a temporal lag of <2 years (Observed/expected close pairs: 124/98; P Knox test = 
0.003). A similar clustering pattern was observed for ALL though overall evidence was 
weaker (Baker’s max at birth P = 0.13). Little evidence of clustering was found for other 
diagnostic groups (P>0.2). Our study suggests that childhood leukaemia tends to cluster in 
space-time due to an etiologic factor present in early life.  
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Introduction 
The aetiology of most childhood cancers remains currently unknown. In developed countries, 
the most frequent diagnostic groups are leukaemia, predominantly acute lymphoid leukaemia 
(ALL), and tumours of the central nervous system (CNS). With the exception of ionizing 
radiation,1 no environmental risk factors for these cancers have been established.2, 3 Several 
infectious agents are known to cause cancer in humans though.4 Among paediatric cancers, 
Burkitt lymphoma and Hodgkin lymphoma are linked with Epstein-Barr virus.4 An infectious 
aetiology has also been proposed for childhood leukaemia.5 The observation of spatial clusters 
of childhood leukaemia cases has led to the suggestion that a specific infection is involved in 
aetiology.6 If specific infectious agents cause cancer in children, incident cases might show a 
tendency to cluster in space and time, i.e. to appear more frequently close in time and space to 
each other than if they occur independently and the risk of disease is spread evenly across the 
study area. Such space-time clustering would best be detectable from residential locations of 
cases at the time of infection, not necessarily at the time of diagnosis when children may have 
relocated. Investigation of the space-time pattern both at birth and at diagnosis may thus help 
uncover the presence and timing of a potentially causative infection.7 
Since the early 1960s numerous studies have investigated space-time clustering of childhood 
leukaemia (studies up to 2004 were reviewed by McNally and Eden8 and Little9). The 
majority of these studies found evidence of space-time clustering around the time of 
diagnosis,10-18 birth19-21 or both.22, 23 Space-time clustering was most pronounced for small 
spatial and temporal lags of a few kilometres and a few months respectively. Studies that did 
not find evidence of space-time clustering typically either had small study samples24, 25 or 
used relatively large spatial units of analysis such as municipalities or bigger administrative 
areas in search of local clusters.26, 27 Separate analyses around diagnosis by age group suggest 
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that space-time clustering is relatively more apparent in younger children (≤5 years) than in 
older ones.10, 11, 13, 15, 17 
A number of studies have reported space-time clustering for other major diagnostic groups of 
childhood cancer including tumours of the central nervous system7, 28, 29 and lymphoma7, 18, 22, 
30 but the evidence is more mixed. A notable exception is Burkitt lymphoma for which a 
majority of studies found a positive association.31-33 
Assessing space-time clustering poses some methodological challenges, however. Statistical 
tests are typically based on data from cases only, and uneven shifts in the underlying 
population are liable to bias results. Rapid population growth in certain areas but not in others 
can mimic the effects of spatio-temporal clusters by increasing the number of cases in the 
former, even though incidence rates remain constant throughout space and time, leading to 
erroneous conclusions about a clustering effect.34 Few studies have attempted to correct for 
this13, 35 and none could consider population shifts at a very small geographic scale. In 
addition, spatial resolution in most studies was low; only a handful of studies were based on 
exact geocodes of children's residential location.15, 36-38 This problem was mitigated to some 
extent though for studies, notably from the U.K., using small area units. Moreover, even 
though space-time clustering analyses were commonly performed for different space-time 
lags and diagnostic groups, few studies explicitly corrected for multiple testing;12, 20, 35 the 
majority of recent studies bypassed this problem by using spatio-temporal K-functions to test 
for evidence of space-time clustering.7, 10, 11, 21  
In the current study, we investigated the presence of space-time clustering of childhood 
cancers in Switzerland using precise residential locations. We focused on the major diagnostic 
groups, namely leukaemia, ALL, CNS tumours, neuroblastomas and soft tissue sarcomas. 
Cases were identified from the Swiss Childhood Cancer Registry for the period 1985-2010. 
We paid special attention to correct for uneven population growth over the study period by 
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sampling representative control locations using a combination of census data and small-area 
population statistics. Exact geocodes of the residential locations were available for the entire 
population at census and at the time of birth and diagnosis for cases. We also corrected for 
multiple testing.  
Material and Methods 
Population 
The study population included cancer cases from the Swiss Childhood Cancer Registry 
(SCCR) diagnosed at age <16 years between January 1, 1985 and December 31, 2010. 
Children were required to be living in Switzerland at diagnosis. The SCCR is a nationwide 
population-based registry with an estimated coverage of 91% of cancers diagnosed in 
Switzerland over this period.39 Since 1995 completeness has been about 95%. From the 
SCCR, we obtained residential address at diagnosis and, for children born in Switzerland, 
address at birth. Addresses were geocoded to the Swissgrid coordinate system through linkage 
with the database of geo-referenced street addresses maintained by Swiss Post (GeoPost) or 
manually using the geoportal of the Swiss Federal Office of Topography 
(www.geo.admin.ch). Precise geocodes to within 50 m were obtained for 94% of available 
residential addresses. The margin of error was <100 m for another 5% while the exact 
location remained uncertain for the remaining less than 1% of addresses. We investigated 
pairs of cancer cases with coordinates at birth or diagnosis <50 m apart for possible sibling 
relationships using patient record data and retained only one record from identified sibling 
pairs.  
In order to correct the analyses for uneven population growth, data on the resident population 
were obtained for the study period 1985-2010. Geocoded residence, municipality of 
residence, age and sex were available for the entire resident population at the time of the 
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Swiss national censuses in 1990, 2000 and 2010 from the Swiss National Cohort study.40 
Population counts by age, sex and municipality were also obtained for the 1980 census. 
Annual data on the total population and number of live births by municipality and sex were 
gathered from the Swiss Federal Office of Statistics. 
Outcomes 
We investigated space-time clustering separately for the following six diagnostic groups 
according to the International Classification of Childhood Cancers, Third Edition41 (ICCC3): 
leukaemia (diagnostic group I), ALL (I.a), lymphomas (II), tumours of the central nervous 
system (CNS) (III), neuroblastomas (IV) and soft tissue sarcomas (IX). For leukaemia and 
ALL we additionally performed clustering analysis for children aged 0-4 and 5-15 years old at 
diagnosis. These groupings were selected because the number of available cases exceeded our 
a priori chosen threshold of 300.  
Sampling of control locations 
In order to account for uneven population shifts, we sampled control locations representing 
the geographic distribution of the general population at the time of cases’ birth and diagnosis, 
respectively. To achieve this, we randomly sampled 999 control locations for each case using 
a two-stage approach: First, municipalities were randomly sampled with replacement, with 
each municipality weighted by the number of age group (0-4, 5-9 and 10-15 years) and sex 
peers residing in that municipality in the case’s year of birth or diagnosis, respectively. For 
the analysis around the time of birth, sampling weights were derived from the number of male 
and female live births. For the analysis around the time of diagnosis, age group and sex 
specific population proportions were computed for every municipality for census years (1980, 
1990, 2000, 2010), and linearly interpolated for the years in-between. Sampling weights were 
then obtained by applying these proportions to annual total population in each municipality. 
At the second stage, residential locations were randomly sampled from the census data (1990, 
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2000 and 2010) among age group and sex peers living in the municipalities selected during 
the first stage. For this we probabilistically selected one of the two censuses closest to the 
cases’ year of birth (or diagnosis). If, for example, a child was born (diagnosed) in 1996, a 
control location was sampled with probability 0.4 and 0.6 from the 1990 and 2000 census, 
respectively. 
Over the study period, mergers and territorial swaps between municipalities were common. 
For the sampling process, we merged neighbouring modified municipalities to ensure that 
they had consistent geographical boundaries throughout the study period.  
Statistical analyses 
Space-time clustering was analysed separately at the time of birth and diagnosis using an 
unbiased version of the Knox test42 as proposed by Kulldorff and Hjalmars34 to adjust for 
uneven regional population shifts. The Knox test statistic counts the number of close pairs of 
cases that occur within a pre-specified spatial and temporal lag of each other. We chose as 
critical values spatial lags of 0.5, 1, 2, 5 and 10 km and temporal lags of 0.5, 1, 1.5 and 2 
years a priori in accordance with previous studies. The spatial lag between two cases was 
calculated as the Euclidean distance between residential coordinates.  
We standardized the counts of close pairs using empirical expected values and standard errors 
as proposed by Barton and David 43 (Standardized counts are referred to here as z-values). A 
null distribution for z-values was obtained by calculating z-values for each of the 999 datasets 
of sampled control locations accordingly. We calculated the p-value as the number of z-values 
thus obtained that exceeded the empirical z-value divided by 1000. To account for multiple 
testing inherent in computing p-values for all combinations of spatial and temporal lags, we 
used Baker's Max44 method. Under this approach, only the maximum z-value over all 
combinations of spatial and temporal lags was considered. Baker's max p-value equals the 
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fraction of maximum z-values of the random samples that exceed the maximum z-value for 
the empirical data set.  
In order to assess the extent of potential bias due to population shifts, we repeated the 
analyses with the standard approach whereby the null distribution is obtained by random 
permutation of case locations.45 All computations were performed using the R language for 




In total 3,795 cases were eligible in the SCCR data base for analysis. After excluding those 
with missing geocodes and sibling cases, we included 1,485 cases with leukaemia, 996 with 
CNS tumours and 635 with lymphomas in the analysis of space-time clustering at the time of 
diagnosis (Figure 1). After additionally excluding children born before 1985, born abroad or 
with uncertain country of birth, corresponding numbers included in analyses at the time of 
birth were 1,052, 689 and 353 respectively. Table 1 indicates the number of cases by 
diagnostic group, age group and gender included in the analysis.  
The frequency distributions of the six diagnostic groups by age group and sex categories 
reflect known incidence patterns. The frequencies of the subtypes of leukaemia are typical for 
industrialised countries: of the 1,052 cases included in the analysis around birth, 852 were of 
type ALL and 147 were acute myeloid leukaemias (AML). Among the cases of ALL, 731 
were of the precursor B-cell subtype or 'common ALL' (cALL) and 88 were of the precursor 
T-cell subtype with the remainder being either unspecified precursor cell leukaemias or 
Burkitt-cell leukaemias. Cases of ALL show the characteristic childhood peak with 447 being 
diagnosed in children aged 2-5 years, of which 89% were of the precursor B-cell subtype. 
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Space‐time clustering 
Results of tests for space-time clustering adjusted for multiple testing over different spatial 
and temporal lags are shown in Table 2. For leukaemia, we found evidence of space-time 
clustering around the time of birth (P = 0.045) but not around diagnosis (P = 0.9841). By 
contrast, we found no evidence of space-time clustering for lymphomas and tumours of the 
central nervous system, neither around birth nor around diagnosis (P>0.5). Detailed results 
from individual Knox tests for the different diagnostic groups are shown in Tables 3-4 and 
Figure 2 and in the supplementary Tables S1-S18 and Figure S1.  
For leukaemia, evidence of space time-clustering around birth was strongest for spatial lags of 
<1 km and <2 km combined with temporal lags of <1.5 and <2 years (Table 3). For 
comparability across different lags and diagnostic groups, the results of the Knox tests are 
reported in Figure 2 as standardized numbers of close pairs (z-values) and as absolute 
numbers of close pairs in excess of the numbers expected. There were 124 pairs of children 
with leukaemia who were born <1 km and <2 years apart, 27% more than the 98 expected (P 
= 0.003; Table 3, Figure 2). Similar effect sizes were observed for leukaemia in children aged 
0-4 years old; there were 19% more close pairs than expected among children born <1 km and 
<2 years apart (P = 0.13; Table 4). The clustering effect for the same spatial and temporal lags 
was considerably weaker for children aged 5-15 years old (10% more close pairs than 
expected, P = 0.30, Supplementary Table S1).  
For ALL, although not statistically significant after adjustment for multiple tests (Table 2), we 
observed an almost identical pattern of space-time clustering at birth, which is not surprising 
as the large majority of leukaemia cases had ALL (Table 1). A 27% excess of close pairs was 
observed for the lags of <1 km and <2 years (P < 0.013; Supplementary Table S2). As with 
leukaemia, there was no evidence of space-time clustering around the place and time of 
diagnosis (Table 2).  
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Some indications from individual Knox tests of possible space-time clustering of cancers 
other than leukaemia are noteworthy, although not statistically significant after correcting for 
multiple testing (Table 2): For neuroblastomas around time of birth and lags <10 km and <2 
years, there were 182 observed close pairs compared to 156 expected, an excess of 16% (P = 
0.019; Supplementary Table S7, Figure 2). For soft tissue sarcomas around time of birth and 
lags <5 km and <2 years, 51 instead of 39 expected close pairs were observed, an excess of 
31% (P = 0.027; Supplementary Table S8, Figure 2).  
There was little difference between the results with or without adjustment for uneven regional 
population shifts: Whether the null distribution was computed by random permutation of case 
locations or by random sampling of control locations from the general population resulted in 
almost identical p-values of individual Knox tests. For leukaemia around the time of birth and 
lags <1 km and <2 years, these P-values were 0.004 and 0.003, respectively.  
Discussion 
Summary of results 
In this nationwide study, which paid special attention to avoiding confounding by uneven 
population growth, we found evidence of space-time clustering of childhood leukaemia 
around the place and time of birth. Evidence was strongest for clustering at a small spatial lag 
of <1 km and a temporal lag of <2 years. The same pattern was observed for ALL. By 
contrast, there was no evidence of space-time clustering of childhood leukaemia around 
diagnosis. We also found little evidence of space-time clustering for lymphomas and tumours 
of the central nervous system. There were, however, indications of space-time clustering of 
neuroblastomas (<10 km; <2 years) and soft tissue sarcomas (<5 km; <2 years) around birth 
that did not reach conventional significance levels after adjusting for multiple testing. 
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Discussion of results in the context of earlier studies 
Our findings agree with most previous studies investigating space time clustering of 
leukaemia at birth.20-22 As in these studies, we found the effect of space-time clustering was 
most pronounced for short spatial lags of 1-2 kilometres, whereas the corresponding temporal 
lag of <2 years in our study was slightly longer than the critical values observed elsewhere. 
Studies using large samples generally found evidence of space-time clustering of leukaemia 
cases at birth, with one notable exception7 that used as distance metric for the space-time 
clustering analysis distance to cases' nearest neighbours (which varies with population 
density) rather than a fixed distance threshold. 
The lack of space-time clustering of leukaemia at diagnosis in our analysis stands in contrast 
to findings from previous studies, a majority of which were positive.11, 15, 22 However, our 
results concur with three mid-sized studies looking at incident cases of ALL which also found 
evidence of space-time clustering at birth but not at diagnosis.19-21 Still, studies with large 
samples typically detected a clustering effect at diagnosis.13, 30 Two recent large studies that 
found no effect were looking for local clusters relying on relatively large units of analysis.26, 27 
In our analysis, the lack of significant evidence does not imply absence of any space-time 
clustering at diagnosis though. For children aged 0-4 years old, the effect sizes for spatial lags 
<2 km and temporal lags of <2 years indicate an excess of pairs close in space and time, even 
if no individual Knox test is below the conventional 5%-level of significance.  
Similar to our results, a number of previous studies did not find evidence of space-time 
clustering of lymphoma or CNS tumours.11, 20, 35 McNally et al.11 found no evidence of 
clustering at diagnosis for either, even though their study sample (n = 32'295) was presumably 
large enough and spatial resolution high enough to detect any important effect. By contrast, 
some studies have reported space-time clustering for these diagnostic groups.7, 28, 30 McNally 
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et al.7 found evidence of strong clustering of Hodgkin lymphomas and moderate clustering of 
CNS tumours at birth.  
Few studies have investigated space-time clustering of neuroblastomas and soft tissue 
sarcomas. McNally et al.47 found no significant clustering effect for neuroblastomas neither at 
birth nor at diagnosis. McNally et al. found evidence of space-time clustering for soft tissue 
sarcomas at diagnosis at spatial and temporal lags similar to our results,11 but no effect around 
birth.7  
Strengths and weaknesses 
Notwithstanding this being a nationwide study, statistical power may have been too low for 
some of the investigated diagnostic groups to detect space-time clustering. Though coverage 
of the SCCR is high, our study could not include all cancer cases that actually occurred. An 
under ascertainment of cases might have diluted the observed tendency for clustering. Some 
cases were also lost to analyses due to missing geocodes. Moreover, for our adjustment for 
uneven population shifts precise locations of residence were known for the entire population 
only at census time points. Thus our sampling of control locations may have been imperfect - 
although it did account for annual population fluctuations at the municipal level. 
The major strength of our study was the availability of precise geocodes for place of residence 
for both cases and the entire child population. This not only allowed us to investigate space-
time clustering at small spatial scales but also made it possible to adjust for potential bias due 
to uneven population growth. To our knowledge, no previous study of childhood cancers has 
applied this methodology at such high spatial resolution; Hjalmars et al.35 had to rely on 
parishes as units of analysis. Other studies of space-time clustering either used similarly large 
units of analysis13 or - if geocodes for residential addresses were available - resorted to 
interrupting the study period in an effort to reduce bias due to uneven population shifts.18, 22 In 
our study, the results from the adjusted analyses differed little from those following the 
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standard approach of random permutation of case locations – which cannot capture uneven 
regional population shifts - suggesting that such a bias, if present, was small. This finding is 
noteworthy given the long study period of 26 years and suggests that bias from uneven 
population shifts can probably be excluded for the current analysis and raises confidence in 
results from other studies that could not account for this at all. Moreover, we took further 
steps to reduce the risk of producing spurious evidence of space-time clustering by adjusting 
for multiple testing.  
Interpretation and conclusions 
The space-time clustering of childhood leukaemia around the time of birth observed in the 
present study thus appears to be real rather than a spurious effect of uneven population 
growth. The finding is also supported by a majority of other studies. This suggests that a 
substantial number of close pairs of leukaemia cases (as many as exceed chance) are likely to 
share etiological factors that clustered temporally in their neighbourhood. The small spatial 
scale of the clustering could be indicative of an infection.  
Evidence of space-time clustering was strongest for a temporal lag of two years, which is a 
relatively long time period considering that local epidemics can be short lived. However, 
while this finding would be compatible with an extended period of locally increased exposure 
to a risk factor e.g. a longer lasting epidemic or environmental hazard, it is also compatible 
with a short-lived increase in exposure combined with an extended age window of 
susceptibility. The observed pattern of clustering might for instance occur if children aged 0-2 
years were susceptible to the leukaemogenic effects of an infection that tends to come about 
as short and highly localised mini-epidemics. 
The results of the current study thus give further credence to the hypothesis that an infectious 
agent might be involved in the aetiology of childhood leukaemia. Several hypotheses 
regarding a possible role of infections have been proposed. Kinlen6 conjectured that childhood 
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leukaemia is a rare response to a common, yet unidentified subclinical infection. Kinlen6 
suggested that situations of ‘population mixing’ – large-scale influxes of urban migrants into 
previously isolated rural communities – could result in localised epidemics and a subsequent 
increase in childhood leukaemia rates. Greaves,5 seeking to explain the peak incidence of the 
precursor B-cell type or 'common' ALL at ages 2-5 years, speculated that the lack of exposure 
to common early childhood infections in modern, 'hygienic' societies might render the 
immune system prone to a pathological response to later, 'delayed' infections. Greaves5 
posited a 'two-hits' model in which a first hit occurring in utero induces chromosomal changes 
in a precursor B-cell that is passed on to daughter cells while infections were hypothesized to 
play a crucial role in the second hit prompting the onset of overt leukaemia. Smith48 proposed 
that the childhood peak in ALL characteristic of more affluent societies might be due to an 
infection that occurred in utero.  
The evidence in our analysis of space-time interaction around the place and time of birth but 
not around the place and time of diagnosis suggests that such an infection would have to 
occur in utero – as suggested by Smith48 – or in early life. Smith48 named as a candidate 
infectious agent the JC virus of the polyomavirus family. However, studies searching for viral 
genomes, including JC virus, in ALL cells or in neonatal blood spots have consistently 
reported negative results.49, 50 Stratification of our analyses by age at diagnosis (0-4, 5-15 
years) reduced the measured effect sizes, suggesting that cases implicated in clustering were 
born close to each other in time but diagnosed at widely differing ages. We therefore 
speculate that an infectious agent could be involved in early disease initiating events, and that 
these events are followed by protracted and variable latent periods or require secondary events 
for disease onset. Greaves’5 'two-hits' model posited no particular environmental stimuli for 
the first hit occurring in utero and these could in principle include infections and thus provide 
a possible explanation for the pattern of space-time clustering observed in our analysis. 
However, Greaves5 assumed infections to play a crucial role in the second postnatal hit yet in 
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our analysis cases of ALL aged 0-4 years old at the time of diagnosis showed an overhang of 
close pairs but no evidence of space-time interaction at conventional significance levels 
(Supplementary Table S13). Kinlen’s hypothesis is a less plausible explanation for our finding 
of spatio-temporal clustering at birth as the critical time point for infection is assumed to be 
closer to the time of diagnosis.6, 51 However, Kinlen refers to a very particular migratory 
pattern, so the absence of significant space-time clustering around the time of diagnosis in this 
nationwide study cannot be taken as evidence against his population mixing hypothesis.  
Our analyses provide few clues with regard to differences in aetiology between the subtypes 
of leukaemia. We ran separate analyses of ALL as it represents a large and relatively 
homogenous subgroup but because of the small sample sizes we did not consider subgroups 
such as cALL or specific cytogenetic subtypes. While it is possible that the observed space-
time clustering is driven by one or a few subtypes, the fact that effects sizes for ALL were 
similar to those for all subtypes of leukaemia combined may indicate that the two broad 
subgroups AML and ALL and perhaps the smaller subdivisions are similarly affected. 
The lack of significant evidence for the other major diagnostic groups does not necessarily 
mean absence of space-time clustering. Our analyses may have lacked the statistical power 
needed to detect effects of clustering for these groups while correcting for multiple testing. 
The effect sizes of the Knox tests of neuroblastomas and soft tissue sarcomas, which were 
comparable to those for leukaemia/ALL, indeed suggest that this may be the case. 
Alternatively, if indeed there is space-time clustering around birth and few children migrate 
between birth and diagnosis, the peak incidence of leukaemia at 2-5 years of age could induce 
a weaker, time-shifted clustering pattern at diagnosis which may be detectable in large studies 
only. In our study 34% of leukaemia cases moved house between birth and diagnosis. 
Unfortunately migration pattern were almost never reported by other investigators, with the 
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exception of Birch et al.10 who reported a slightly higher rate. Birch et al.10 found evidence of 
space-time clustering around place and time of diagnosis but not around birth. 
The presence of space-time clustering also does not necessarily imply infections but could 
point to other localized hazards present for a limited period of time. What the current study 
did not analyse is the presence of purely spatial clustering, which could be triggered by a 
more permanent local environmental hazard. The Knox test is insensitive to localized hazards 
leading to continuously elevated risks.  
In conclusion, our study suggests that children who develop leukaemia show a tendency to 
cluster in time and space at birth and that this tendency is not explained by regional 
population shifts. The prima facie evidence of the observed space-time clustering pattern 
suggests that an infectious agent is involved in aetiology but further research is necessary to 
assess the potential influence of environmental risk factors. 
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Figure legends 
Fig. 1 Flow chart of study population 
 
Fig. 2 Standardized numbers of close pairs of cases in excess of expected numbers (z-values) 
for different diagnostic groups for all combinations of spatial and temporal lags around the 
place and time of birth. Figures at the bottom of the bars indicate absolute numbers of excess 
close pairs 
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Table S1 Results of Knox tests of cases of leukaemia at place and time of birth of children 
aged 5-15 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  0/1.6  2/3.2  3/4.7  6/6.2 
0.5 km  Ratio  0.00  0.63  0.64  0.97 
   p‐value  0.928  0.759  0.823  0.570 
  Obs./Exp.  4/4.7  12/9.2  15/13.7  20/18.1 
1 km  Ratio  0.85  1.30  1.09  1.10 
   p‐value  0.588  0.162  0.355  0.304 
  Obs./Exp.  8/12.0  24/23.6  37/35.1  48/46.3 
2 km  Ratio  0.67  1.02  1.05  1.04 
   p‐value  0.889  0.462  0.359  0.381 
  Obs./Exp.  40/43.4  84/85.2  134/126.6  166/167.0 
5 km  Ratio  0.92  0.99  1.06  0.99 
   p‐value  0.690  0.509  0.224  0.500 
Obs./Exp.  103/110.5  218/216.8  337/322.3  431/425.1 
10 km  Ratio  0.93  1.01  1.05  1.01 
   p‐value  0.780  0.455  0.207  0.369 
 
  
Table S2 Results of Knox tests of cases of acute lymphoid leukaemia at place and time of 
birth of children aged 0-15 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  3/5.9  11/11.5  20/17.2  31/22.7 
0.5 km  Ratio  0.51  0.95  1.17  1.37 
   p‐value  0.927  0.623  0.296  0.059 
  Obs./Exp.  12/17.4  35/34.1  62/50.7  85/67.1 
1 km  Ratio  0.69  1.03  1.22  1.27 
   p‐value  0.919  0.449  0.047  0.013 
  Obs./Exp.  34/42.4  79/83.2  134/123.7  181/163.7 
2 km  Ratio  0.80  0.95  1.08  1.11 
   p‐value  0.911  0.675  0.155  0.066 
  Obs./Exp.  128/155.8  278/305.8  453/454.8  592/601.7 
5 km  Ratio  0.82  0.91  1.00  0.98 
   p‐value  0.984  0.930  0.479  0.578 
Obs./Exp.  354/373.0  729/732.0  1086/1088.5  1440/1440.1 
10 km  Ratio  0.95  1.00  1.00  1.00 
   p‐value  0.833  0.503  0.459  0.410 
 
  
Table S3 Results of Knox tests of cases of acute lymphoid leukaemia at place and time of 
birth of children aged 0-4 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  1/2.4  4/4.6  5/6.8  9/9.0 
0.5 km  Ratio  0.43  0.87  0.74  1.00 
   p‐value  0.856  0.646  0.797  0.573 
  Obs./Exp.  3/6.2  10/12.1  20/17.9  27/23.6 
1 km  Ratio  0.49  0.83  1.12  1.14 
   p‐value  0.934  0.757  0.327  0.258 
  Obs./Exp.  12/15.6  25/30.4  47/45.1  61/59.5 
2 km  Ratio  0.77  0.82  1.04  1.03 
   p‐value  0.816  0.859  0.383  0.416 
  Obs./Exp.  45/60.2  94/117.3  169/174.0  221/229.7 
5 km  Ratio  0.75  0.80  0.97  0.96 
   p‐value  0.981  0.986  0.652  0.718 
Obs./Exp.  135/137.1  256/267.3  393/396.7  515/523.5 
10 km  Ratio  0.98  0.96  0.99  0.98 
   p‐value  0.577  0.744  0.578  0.641 
 
  
Table S4 Results of Knox tests of cases of acute lymphoid leukaemia at place and time of 
birth of children aged 5-15 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  0/1.1  1/2.3  2/3.4  5/4.5 
0.5 km  Ratio  0.00  0.44  0.60  1.12 
   p‐value  0.912  0.828  0.822  0.397 
  Obs./Exp.  2/3.2  7/6.3  9/9.4  13/12.5 
1 km  Ratio  0.62  1.10  0.95  1.04 
   p‐value  0.759  0.406  0.586  0.449 
  Obs./Exp.  5/7.2  16/14.1  23/21.0  30/27.8 
2 km  Ratio  0.70  1.14  1.10  1.08 
   p‐value  0.799  0.299  0.302  0.303 
  Obs./Exp.  19/24.5  47/48.2  76/71.7  95/95.0 
5 km  Ratio  0.78  0.98  1.06  1.00 
   p‐value  0.885  0.568  0.304  0.504 
Obs./Exp.  60/65.0  127/127.9  195/190.3  251/252.1 
10 km  Ratio  0.92  0.99  1.02  1.00 
   p‐value  0.777  0.618  0.393  0.550 
 
  
Table S5 Results of Knox tests of cases of tumors of the central nervous system at place and 
time of birth of children aged 0-15 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  1/3.5  9/6.9  10/10.5  12/13.8 
0.5 km  Ratio  0.29  1.29  0.96  0.87 
   p‐value  0.943  0.229  0.583  0.756 
  Obs./Exp.  8/10.6  20/21.3  29/32.1  37/42.4 
1 km  Ratio  0.75  0.94  0.90  0.87 
   p‐value  0.828  0.621  0.714  0.826 
  Obs./Exp.  25/29.7  54/59.6  76/89.7  104/118.6 
2 km  Ratio  0.84  0.91  0.85  0.88 
   p‐value  0.819  0.773  0.934  0.920 
  Obs./Exp.  112/108.9  225/218.2  319/328.4  424/434.3 
5 km  Ratio  1.03  1.03  0.97  0.98 
   p‐value  0.385  0.318  0.674  0.674 
Obs./Exp.  259/253.0  514/507.0  760/762.9  1009/1008.9 
10 km  Ratio  1.02  1.01  1.00  1.00 
   p‐value  0.374  0.374  0.505  0.463 
 
  
Table S6 Results of Knox tests of cases of lymphomas at place and time of birth of children 
aged 0-15 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  1/1.4  2/2.8  3/4.1  4/5.4 
0.5 km  Ratio  0.72  0.73  0.74  0.75 
   p‐value  0.635  0.665  0.708  0.759 
  Obs./Exp.  1/3.5  3/7.0  8/10.3  11/13.6 
1 km  Ratio  0.28  0.43  0.77  0.81 
   p‐value  0.939  0.958  0.788  0.773 
  Obs./Exp.  10/9.6  18/19.1  24/28.2  29/37.0 
2 km  Ratio  1.04  0.94  0.85  0.78 
   p‐value  0.441  0.605  0.802  0.920 
  Obs./Exp.  30/33.3  64/66.1  95/97.5  117/128.2 
5 km  Ratio  0.90  0.97  0.97  0.91 
   p‐value  0.695  0.600  0.586  0.854 
Obs./Exp.  71/76.6  147/151.9  220/224.1  287/294.7 
10 km  Ratio  0.93  0.97  0.98  0.97 
   p‐value  0.753  0.676  0.608  0.677 
 
  
Table S7 Results of Knox tests of cases of neuroblastomas at place and time of birth of 
children aged 0-15 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  0/0.4  0/0.8  0/1.2  1/1.5 
0.5 km  Ratio  0.00  0.00  0.00  0.65 
   p‐value  0.568  0.758  0.875  0.699 
  Obs./Exp.  0/1.1  1/2.1  1/3.2  3/4.3 
1 km  Ratio  0.00  0.47  0.31  0.70 
   p‐value  0.808  0.804  0.919  0.759 
  Obs./Exp.  3/3.8  6/7.4  11/11.2  17/14.9 
2 km  Ratio  0.80  0.81  0.98  1.14 
   p‐value  0.640  0.694  0.528  0.269 
  Obs./Exp.  18/14.8  30/29.0  48/44.1  69/58.5 
5 km  Ratio  1.22  1.03  1.09  1.18 
   p‐value  0.186  0.412  0.255  0.081 
Obs./Exp.  44/39.4  90/77.5  136/117.8  182/156.3 
10 km  Ratio  1.12  1.16  1.15  1.16 
   p‐value  0.197  0.068  0.048  0.019 
 
  
Table S8 Results of Knox tests of cases of soft tissue sarcomas at place and time of birth of 
children aged 0-15 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  1/0.4  2/0.7  2/1.1  3/1.4 
0.5 km  Ratio  2.84  2.84  1.90  2.16 
   p‐value  0.145  0.081  0.174  0.079 
  Obs./Exp.  2/0.8  4/1.7  4/2.5  6/3.3 
1 km  Ratio  2.39  2.39  1.60  1.82 
   p‐value  0.106  0.049  0.145  0.065 
  Obs./Exp.  5/2.9  8/5.7  10/8.5  14/11.3 
2 km  Ratio  1.75  1.40  1.17  1.24 
   p‐value  0.116  0.151  0.279  0.184 
  Obs./Exp.  15/9.9  28/19.7  36/29.4  51/38.9 
5 km  Ratio  1.52  1.42  1.22  1.31 
   p‐value  0.060  0.030  0.099  0.027 
Obs./Exp.  26/23.9  53/47.9  68/71.5  95/94.4 
10 km  Ratio  1.09  1.11  0.95  1.01 
   p‐value  0.296  0.212  0.627  0.440 
 
  
Table S9 Results of Knox tests of cases of leukaemia at place and time of diagnosis of 
children aged 0-15 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  13/13.3  23/26.4  40/39.2  53/51.8 
0.5 km  Ratio  0.97  0.87  1.02  1.02 
   p‐value  0.782  0.915  0.718  0.669 
  Obs./Exp.  38/36.9  64/72.9  106/108.5  140/143.4 
1 km  Ratio  1.03  0.88  0.98  0.98 
   p‐value  0.583  0.927  0.749  0.724 
  Obs./Exp.  91/101.3  180/200.2  283/297.9  372/393.5 
2 km  Ratio  0.90  0.90  0.95  0.95 
   p‐value  0.895  0.957  0.865  0.916 
  Obs./Exp.  339/373.0  690/737.0  1058/1096.7  1400/1448.7 
5 km  Ratio  0.91  0.94  0.96  0.97 
   p‐value  0.967  0.969  0.897  0.931 
Obs./Exp.  904/946.6  1806/1870.5  2761/2783.4  3663/3676.8 
10 km  Ratio  0.95  0.97  0.99  1.00 
   p‐value  0.930  0.950  0.692  0.620 
 
  
Table S10 Results of Knox tests of cases of leukaemia at place and time of diagnosis of 
children aged 0-4 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  5/4.0  10/8.1  14/12.0  19/15.9 
0.5 km  Ratio  1.24  1.24  1.16  1.19 
   p‐value  0.633  0.561  0.615  0.522 
  Obs./Exp.  15/9.8  23/19.7  33/29.4  43/38.9 
1 km  Ratio  1.53  1.17  1.12  1.11 
   p‐value  0.126  0.389  0.387  0.387 
  Obs./Exp.  31/26.7  61/53.5  81/79.7  105/105.6 
2 km  Ratio  1.16  1.14  1.02  0.99 
   p‐value  0.260  0.190  0.518  0.601 
  Obs./Exp.  103/101.9  208/204.2  300/304.4  391/403.2 
5 km  Ratio  1.01  1.02  0.99  0.97 
   p‐value  0.516  0.443  0.629  0.740 
Obs./Exp.  257/248.7  494/498.4  743/743.0  975/984.0 
10 km  Ratio  1.03  0.99  1.00  0.99 
   p‐value  0.345  0.612  0.513  0.623 
 
  
Table S11 Results of Knox tests of cases of leukaemia at place and time of diagnosis of 
children aged 5-15 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  4/3.3  4/6.4  11/9.6  13/12.6 
0.5 km  Ratio  1.21  0.62  1.15  1.03 
   p‐value  0.341  0.852  0.332  0.471 
  Obs./Exp.  10/8.3  13/16.2  22/24.2  27/31.8 
1 km  Ratio  1.20  0.80  0.91  0.85 
   p‐value  0.287  0.801  0.686  0.830 
  Obs./Exp.  21/22.9  31/44.6  52/66.7  67/87.7 
2 km  Ratio  0.92  0.69  0.78  0.76 
   p‐value  0.635  0.991  0.983  0.996 
  Obs./Exp.  61/84.3  128/164.1  221/245.1  293/322.4 
5 km  Ratio  0.72  0.78  0.90  0.91 
   p‐value  0.998  0.997  0.960  0.964 
Obs./Exp.  183/223.3  371/434.5  619/648.8  823/853.4 
10 km  Ratio  0.82  0.85  0.95  0.96 
   p‐value  0.999  0.999  0.913  0.886 
 
  
Table S12 Results of Knox tests of cases of acute lymphoid leukaemia at place and time of 
diagnosis of children aged 0-15 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  9/7.8  14/15.5  25/23.0  32/30.4 
0.5 km  Ratio  1.15  0.91  1.09  1.05 
   p‐value  0.608  0.861  0.595  0.613 
  Obs./Exp.  26/22.6  43/44.7  72/66.5  90/87.9 
1 km  Ratio  1.15  0.96  1.08  1.02 
   p‐value  0.382  0.746  0.361  0.526 
  Obs./Exp.  60/63.6  117/125.8  191/187.1  244/247.4 
2 km  Ratio  0.94  0.93  1.02  0.99 
   p‐value  0.734  0.837  0.440  0.651 
  Obs./Exp.  220/234.2  430/463.0  671/688.7  883/910.5 
5 km  Ratio  0.94  0.93  0.97  0.97 
   p‐value  0.846  0.959  0.789  0.853 
Obs./Exp.  577/598.6  1142/1183.5  1755/1760.6  2346/2327.5 
10 km  Ratio  0.96  0.96  1.00  1.01 
   p‐value  0.845  0.913  0.577  0.389 
 
  
Table S13 Results of Knox tests of cases of acute lymphoid leukaemia at place and time of 
diagnosis of children aged 0-4 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  5/2.9  8/5.7  12/8.5  14/11.3 
0.5 km  Ratio  1.74  1.39  1.41  1.24 
   p‐value  0.361  0.465  0.341  0.486 
  Obs./Exp.  11/6.9  17/13.7  26/20.4  32/27.0 
1 km  Ratio  1.60  1.24  1.27  1.19 
   p‐value  0.161  0.345  0.204  0.289 
  Obs./Exp.  18/19.1  40/38.1  57/56.6  72/74.9 
2 km  Ratio  0.94  1.05  1.01  0.96 
   p‐value  0.702  0.460  0.542  0.714 
  Obs./Exp.  68/72.6  140/144.8  206/214.9  266/284.5 
5 km  Ratio  0.94  0.97  0.96  0.94 
   p‐value  0.758  0.694  0.741  0.872 
Obs./Exp.  176/176.7  345/352.3  520/523.0  687/692.2 
10 km  Ratio  1.00  0.98  0.99  0.99 
   p‐value  0.573  0.706  0.587  0.600 
 
  
Table S14 Results of Knox tests of cases of acute lymphoid leukaemia at place and time of 
diagnosis of children aged 5-15 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  1/1.7  1/3.3  6/4.9  7/6.5 
0.5 km  Ratio  0.59  0.30  1.22  1.07 
   p‐value  0.679  0.920  0.319  0.447 
  Obs./Exp.  5/4.3  6/8.4  12/12.6  14/16.6 
1 km  Ratio  1.17  0.72  0.96  0.84 
   p‐value  0.340  0.805  0.556  0.769 
  Obs./Exp.  14/12.9  20/25.2  35/37.7  44/49.9 
2 km  Ratio  1.09  0.79  0.93  0.88 
   p‐value  0.338  0.859  0.677  0.833 
  Obs./Exp.  37/45.5  70/88.9  124/133.2  164/176.2 
5 km  Ratio  0.81  0.79  0.93  0.93 
   p‐value  0.910  0.989  0.819  0.853 
Obs./Exp.  97/122.7  204/239.9  344/359.3  461/475.4 
10 km  Ratio  0.79  0.85  0.96  0.97 
   p‐value  0.994  0.996  0.829  0.798 
 
  
Table S15 Results of Knox tests of cases of tumors of the central nervous system at place and 
time of diagnosis of children aged 0-15 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  8/6.9  18/13.7  22/20.5  31/27.2 
0.5 km  Ratio  1.16  1.31  1.07  1.14 
   p‐value  0.378  0.144  0.390  0.257 
  Obs./Exp.  20/20.0  41/39.8  61/59.3  82/78.6 
1 km  Ratio  1.00  1.03  1.03  1.04 
   p‐value  0.496  0.456  0.433  0.371 
  Obs./Exp.  49/51.4  102/102.3  143/152.5  186/202.2 
2 km  Ratio  0.95  1.00  0.94  0.92 
   p‐value  0.620  0.493  0.806  0.891 
  Obs./Exp.  197/196.2  403/390.2  577/581.6  764/770.8 
5 km  Ratio  1.00  1.03  0.99  0.99 
   p‐value  0.481  0.254  0.564  0.583 
Obs./Exp.  492/471.8  972/938.5  1414/1398.8  1853/1854.1 
10 km  Ratio  1.04  1.04  1.01  1.00 
   p‐value  0.184  0.151  0.360  0.521 
 
  
Table S16 Results of Knox tests of cases of lymphomas at place and time of diagnosis of 
children aged 0-15 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  5/2.8  6/5.6  7/8.4  8/11.0 
0.5 km  Ratio  1.77  1.07  0.84  0.72 
   p‐value  0.111  0.429  0.671  0.844 
  Obs./Exp.  9/7.1  14/14.1  22/21.0  28/27.8 
1 km  Ratio  1.27  0.99  1.05  1.01 
   p‐value  0.233  0.504  0.394  0.455 
  Obs./Exp.  25/19.7  43/39.2  63/58.6  76/77.3 
2 km  Ratio  1.27  1.10  1.08  0.98 
   p‐value  0.120  0.257  0.268  0.564 
  Obs./Exp.  78/76.5  147/152.0  215/227.2  292/299.8 
5 km  Ratio  1.02  0.97  0.95  0.97 
   p‐value  0.442  0.670  0.807  0.681 
Obs./Exp.  186/181.2  342/359.8  514/537.7  684/709.6 
10 km  Ratio  1.03  0.95  0.96  0.96 
   p‐value  0.384  0.850  0.860  0.844 
 
  
Table S17 Results of Knox tests of cases of neuroblastomas at place and time of diagnosis of 
children aged 0-15 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  2/0.8  2/1.6  4/2.4  4/3.1 
0.5 km  Ratio  2.39  1.23  1.69  1.29 
   p‐value  0.172  0.424  0.204  0.383 
  Obs./Exp.  3/1.8  4/3.6  8/5.2  8/6.8 
1 km  Ratio  1.64  1.12  1.54  1.17 
   p‐value  0.222  0.410  0.118  0.333 
  Obs./Exp.  4/5.4  9/10.5  18/15.3  21/20.2 
2 km  Ratio  0.74  0.85  1.17  1.04 
   p‐value  0.749  0.707  0.254  0.439 
  Obs./Exp.  22/20.1  36/39.1  58/56.9  73/74.8 
5 km  Ratio  1.10  0.92  1.02  0.98 
   p‐value  0.424  0.757  0.516  0.673 
Obs./Exp.  56/50.4  104/98.1  152/142.7  194/187.8 
10 km  Ratio  1.11  1.06  1.07  1.03 
   p‐value  0.279  0.309  0.274  0.382 
 
  
Table S18 Results of Knox tests of cases of soft tissue sarcomas at place and time of 
diagnosis of children aged 0-15 years old 
      Months 
   6  12  18  24 
   Obs./Exp.  2/0.6  2/1.2  3/1.7  3/2.2 
0.5 km  Ratio  3.36  1.71  1.74  1.33 
   p‐value  0.077  0.237  0.189  0.304 
  Obs./Exp.  3/1.8  7/3.6  8/5.3  9/6.9 
1 km  Ratio  1.64  1.95  1.51  1.31 
   p‐value  0.201  0.046  0.143  0.211 
  Obs./Exp.  5/5.2  12/10.1  16/15.0  21/19.5 
2 km  Ratio  0.97  1.19  1.07  1.08 
   p‐value  0.526  0.289  0.397  0.351 
  Obs./Exp.  15/18.7  35/36.7  52/54.4  71/70.7 
5 km  Ratio  0.80  0.95  0.96  1.00 
   p‐value  0.843  0.654  0.658  0.525 
Obs./Exp.  42/48.8  88/95.9  125/142.0  174/184.6 
10 km  Ratio  0.86  0.92  0.88  0.94 
   p‐value  0.860  0.811  0.952  0.828 
 
  
Fig. S1 Standardized numbers of close pairs of cases in excess of expected numbers (z-
values) for different diagnostic groups for all combinations of spatial and temporal lags 
around the place and time of diagnosis. Figures at the bottom of the bars indicate absolute 
numbers of excess close pairs 
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The published Table 2 reports the p-values of space-time clustering tests for the different 
diagnostic groups at place and time of diagnosis based on a Monte Carlo simulation that 
inadvertently used the reference date of the 2000 Swiss national census as date for the census 
in 2010 to sample the random controls from the general population. As a consequence, 
population figures, which during the first stage of the two-stage sampling procedure were 
used as weights to sample municipalities from which to sample the geocodes of actual control 
locations during the second stage, reflected the number of residents aged 10-25 years instead 
of 0-15 years in 2010. These population weights for part of the study period thus reflected an 
older share of the population than the cases. We therefore resampled controls using corrected 
weights and recalculated all tests. This does not alter the overall conclusion of the table: that 
at time of diagnosis there are no diagnostic groups of childhood cancer that show significant 
evidence of space-time clustering after correcting for multiple testing. (Population figures for 
analyses at time of birth were computed based on birth registry data instead of census data 
and remain unaffected.) The authors apologize for this error.  
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Table 2 Results of Space-Time Clustering Analysis by Diagnostic Group around Date/Place 
of Birth and Diagnosis Adjusted for Multiple Testing Using Baker's Max Method 
  N Date/Place of Birth N 
Date/Place 
of Diagnosis 
Leukaemia, 0-15y 1052 0.045 1485 0.984 
Leukaemia, 0-4y 631 0.607 753 0.652 
Leukaemia, 5-15y 421 0.702 732 0.876 
ALL, 0-15y 852 0.129 1185 0.919 
ALL, 0-4y 519 0.822 628 0.717 
ALL, 5-15y 333 0.876 557 0.894 
CNS, 0-15y 689 0.765 996 0.648 
Lymphomas, 0-15y 353 0.951 635 0.577 
Neuroblastomas, 0-15y 268 0.188 310 0.609 
Sarcomas, 0-15y 229 0.244 334 0.328 
 
